Although Tert amplification and insertion of HBV in the Tert promoter has been considered as the alternative mechanism leading to telomerase reactivation in HCC [106, 107], identification of Tert promoter mutations in HCCs has opened new insights into telomerase reactivation and telomere maintenance in liver carcinogenesis. Here, TERT is linked to hepatocellular carcinoma.